IMBRUVICA (ibrutinib) capsules. FDA-Approved

FDA approved Anti-Cancer medicine IMBRUVICA (ibrutinib) capsules is available upon request. To get best retail price of IMBRUVICA (ibrutinib) capsules in India, For emergency product orders call 8750295029 (Mr. Neeraj Nagpal) or For enquires email [email protected] For advanced treatments in India, Medvitaz Pharma Solution can even help patient to discuss with hematologist-oncologist.
IMBRUVICA (ibrutinib) capsules
IMBRUVICA (ibrutinib) capsules Delhi india
Categories: , .

IMBRUVICA (ibrutinib) capsules

INDICATIONS AND USAGE
IMBRUVICA is a kinase inhibitor indicated for the treatment of adult patients with:
• Mantle cell lymphoma (MCL) who have received at least one prior therapy.
• Chronic lymphocytic leukemia (CLL)/Small lymphocytic lymphoma (SLL) .
• Chronic lymphocytic leukemia (CLL)/Small lymphocytic lymphoma (SLL) with 17p deletion
• Waldenström’s macroglobulinemia (WM).
• Marginal zone lymphoma (MZL)
• Chronic graft versus host disease (cGVHD) after failure of one or more lines of systemic therapy.

DOSAGE FORMS & STRENGTHS
Capsules: 70 mg and 140 mg
Tablets: 140 mg, 280 mg, 420 mg, and 560 mg
Manufactured By: Pharmacyclics
Prescribing Information URL: Click Here

HOW TO MAKE AN ENQUIRY FOR IMBRUVICA (ibrutinib) tablets?

FDA approved Anti-Cancer medicine IMBRUVICA (ibrutinib) capsules is available upon request. To get best retail price of IMBRUVICA (ibrutinib) capsules in India, For emergency product orders call 8750295029 (Mr. Neeraj Nagpal) or For enquires email [email protected].  Medvitaz Pharma Solutions can help you to get access to genuine, affordable and assurance of delivery of approved medicines for Blood Cancer. For advanced treatments in India, Medvitaz can even help patient to discuss with hematologist-oncologist.

Description

What Ibrutinib is indicated for?

Ibrutinib, sold under the brand name Imbruvica among others, is a small molecule drug that binds permanently to a protein, Bruton's tyrosine kinase (BTK), that is important in B cells. It is used to treat B cell cancers like mantle cell lymphoma, chronic lymphocytic leukemia, and Waldenström's macroglobulinemia.

How and where to buy Ibrutinib Capsules?

You can order Ibrutinib capsules through Medvitaz Pharma Solutions under Named Patient Program (NPP). Medvitaz provides patients and physicians access to commercially approved medicines that are not available to them in their own country. Medvitaz objectives is to make quality medicines available at affordable prices for patients and physicians. To get best retail price/cost of Ibrutinib capsules in India, Call 8750295029 or Email [email protected]. FDA approved drugs of Australia, Canada, Delhi, EU, India, New Zealand, Singapore, Switzerland, Turkey & USA.

Prev
Next
neeraj
Neeraj Nagpal

Head of Operations

 The profound knowledge of more than 20 years in sales and marketing sector, he has been working dedicatedly and contributing to pharmaceuticals industry. He handles all operations over the country.

Contact Our Team

Contact us and we will reply as soon as possible!

    Get Access to IMBRUVICA (ibrutinib) capsules In India

    Medvitaz Pharma is a Certified Pharmaceutical Wholesaler/ Supplier/ Exporters/ Importer of Anti-Cancer Medicines / Drugs, used in certain cancers (such as mantle cell or marginal zone lymphoma, chronic lymphocytic leukemia/small lymphocytic lymphoma, Waldenstrom’s macroglobulinemia) treatment from India. Submit the request form for cost price of Brand Name “IMBRUVICA (ibrutinib) capsules” or Generic Name “ibrutinib capsules” can be imported for personal use under “patient name basis” treatment in Delhi, Mumbai, Kolkata, Chennai, Bangalore, Hyderabad, Ahmedabad, Pune, Surat, Jaipur, Coimbatore, Noida, Gurgaon, Punjab, Chandigarh, Bhubaneswar, Arunachal Pradesh, Assam, Manipur, Meghalaya, Mizoram, Nagaland, Tripura and Sikkim, India. Once we review your request and delivery process, we’ll send you an estimated price for the medicine within 1-2 days.

    You may be interested in

    ANDEXXA ® (coagulation factor Xa (recombinant), inactivated-zhzo). Lyophilized powder for solution for intravenous injection
    ANDEXXA (coagulation factor Xa (recombinant), inactivated-zhzo). Lyophilized powder for solution for intravenous injection. Initial U.S. Approval: 2018
    XOSPATA ® (gilteritinib) tablets
    XOSPATA (gilteritinib) tablets, for oral use. Initial U.S. Approval: 2018
    YERVOY (ipilimumab) injection
    YERVOY (ipilimumab) injection, for intravenous use. Initial U.S. Approval: 2011
    COPIKTRA (duvelisib), capsules for oral use
    COPIKTRA (duvelisib), capsules for oral use. Initial U.S. Approval: 2018
    REVLIMID [lenalidomide] capsules
    REVLIMID [lenalidomide] capsules, for oral use. Initial US Approval: 2005
    GAZYVA ® (obinutuzumab) injection
    GAZYVA (obinutuzumab) injection, for intravenous infusion. Initial U.S. Approval: 2013